Hematology Oncology Center Adds Xuan Huang, MD, to the Physician Team

/in /by

Dr. Huang is a Board-certified medical oncologist and hematologist and is now accepting new patients.

ELYRIA, Ohio, May 16, 2024 –  Hematology Oncology Center, a partner practice of American Oncology Network (AON) (Nasdaq: AONC), is excited to welcome Board-certified medical oncologist and hematologist Xuan Huang, MD, to its practice, further improving its patient care services and accessibility.

“We are honored to be making this announcement and extending a warm welcome to our newest physician, Dr. Huang,” said Jay Sidloski, DO, a Board-certified medical oncologist at Hematology Oncology Center. “She brings years of experience and expertise in cancer care. By adding an additional oncologist to our team, we can better offer patients the care and treatment they need close to where they live.”

Dr. Huang obtained her doctorate degree in medicine from Beijing Medical University in Beijing, China, and then a doctorate degree in philosophy from New York Medical College in Valhalla, New York. She completed an internal medicine internship and residency at New York Medical College before attending a hematology-oncology fellowship at the National Cancer Institute in Bethesda, Maryland.

“I am passionate about providing my patients with personalized care and treatment plans and look forward to serving patients who have trusted their care to Hematology Oncology Center,” said Dr. Huang. “I pride myself on being an advocate for my patients. It is an honor to be a part of a compassionate team of providers who are dedicated to bringing quality cancer care to the community.”

“Dr. Huang’s care approach is to help patients make informed decisions about their care, truly developing an individualized treatment plan based on each patient,” said Stephen “Fred” Divers, MD, chief medical officer at AON. “We are fortunate to have Dr. Huang join AON and Hematology Oncology Center.”

Dr. Huang has provided patient care for over 10 years in Ohio communities and is now accepting new patients at the clinic’s main location in Elyria.

For more information about AON, visit www.AONcology.com. For more information about Hematology Oncology Center, visit elyriahoc.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

About Hematology Oncology Center
Hematology Oncology Center is a community-based medical oncology and hematology practice serving patients in Lorain County, and the surrounding areas. Our highly trained hematologists and medical oncologists are committed to providing high-quality patient care with the utmost concern for patient comfort and convenience. From our state-of-the-art cancer center, we offer a comprehensive range of personalized treatment options and services. Our exceptional quality care includes home delivery of oral cancer medications from a specialty, in-house pharmacy, timely labs and pathology reports and on-site infusion therapy. We also offer comprehensive supportive care, financial counseling and much more. Learn more at elyriahoc.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

American Oncology Network Advances Karyogram Segmentation and Increases the Speed to Results with New A.I. Software

/in /by

The AON Central Lab is recognized as the first laboratory in the world to use this technology, which decreases analysis time.

FORT MYERS, Fla., May 15, 2024 – American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing community oncology networks, and the AON Central Lab are pleased to announce the implementation of the new cytogenetics A.I. software HiBand v8.4 for karyogram segmentation and classification. AON Central Lab is the first laboratory in the world to utilize this technology.

Cytogenetics A.I. leverages machine learning to screen chromosomes and genetic disorders in real time and then simultaneously segment and categorize them in a karyogram. The process increases efficiency and allows for expedited results processing, serving as a critical support tool in patient care and treatment decision-making.

“We are excited about the software and the benefits it provides to our team and patients,” said Curtiss McNair, AON’s vice president of laboratory services. “The software karyotypes every recognized metaphase, allowing for a swift and thorough analysis every time. Harnessing the power of the new software, we’ve decreased analysis time by 35% to 40%, freeing up our technologists to focus on reviewing additional metaphases for abnormality screening.”

Previously, the AON Central Lab relied on a previous software version that did not include A.I. algorithms. AON technologists meticulously segmented and manipulated chromosomes for karyotyping. The manual process slowed the lead time in which a patient received the results.

“We are committed to our patients, and our continuous goal with any process is to decrease the time between analysis and results so that our patients not only receive the findings within a reasonable timeframe but can take action quicker alongside their physician,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “This software supports us in accelerating analysis processing, which means faster diagnosis and treatment plans and improved patient outcomes. Above all, it results in significant efficiency gains for those involved, from our lab technologists to physicians and their patients.”

The AON Central Lab is recognized as the first laboratory in the world to integrate this version of HiBand into current clinical workflows. It is an innovative A.I. software from Applied Spectral Imaging (ASI), a global provider of brightfield, fluorescence, and spectral imaging solutions that leverage its GenASIs™ technology and algorithms for advanced diagnostics in cytogenetics and pathology.

This cutting-edge technology is currently unavailable to the public, making AON’s lab a true frontrunner in the industry.

“The implementation and adoption of the software comes from our lab’s participation in a recent study featured at the ACMG Conference,” said McNair. “The software has positioned us to deliver more advanced clinical services and patient care. It also illustrates our commitment to continuous improvement within community oncology. It has set us apart by offering patients quicker turnaround time for critical results.”

For more information about AON, visit www.AONcology.com. For more information about the AON Central Lab, visit www.AONcology.com/pathology.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Local Oncologist Named Advocacy Champion by the Association for Clinical Oncology

/in /by

Sakeer Hussain, MD, of Heartland Oncology & Hematology, was recognized for his involvement at the 2024 Advocacy Summit event.

COUNCIL BLUFFS, Iowa, May 14, 2024 –  Sakeer Hussain, MD, Board-certified medical oncologist at Heartland Oncology & Hematology, a partner practice of the American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing community oncology networks, was named an Advocacy Champion by the Association for Clinical Oncology (ASCO) during the Association’s 2024 Advocacy Summit in April.

Advocacy Champions are ASCO volunteers who have made meaningful contributions to ASCO’s advocacy activities throughout the year to ensure that every patient with cancer has access to high-quality, high-value cancer care, no matter who they are or where they live. Advocates speak with federal lawmakers and agencies, send personalized letters to Members of Congress through ASCO’s ACT Network, engage with state lawmakers on policy priorities at the state level, and host site visits for lawmakers in their home states and districts.

“ASCO’s Advocacy Champions are instrumental in making lasting policy changes that positively impact cancer care and research,” said Piyush Srivastava, MD, FASCO, chair of ASCO’s Government Relations Committee. “They have worked tirelessly this year to advance policy that would end drug shortages, provide robust federal funding for cancer research, and expand telehealth flexibilities permanently. Their efforts will affect cancer care providers, researchers, and patients for years to come.”

Throughout the past year, Dr. Hussain has participated in a variety of advocacy activities, including annual visits to Washington, D.C. to meet with Congress representatives and speak on patient care challenges and opportunities such as prior authorization and telemedicine expansion flexibilities. Additionally, he gave testimony in the Iowa House of Representatives against medical switching and has hosted the local congressman at the clinic.

“Being named an ASCO Advocacy Champion is an honor and incredibly humbling, and it is a privilege to contribute to such a worthy cause as ASCO’s advocacy initiatives,” said Dr. Hussain. “Receiving this recognition means a lot to me and is a testament to my ongoing commitment to closing the cancer care gap and removing barriers to accessible cancer care and services. I look forward to continuing to fight for a system where everyone has access to the cancer care they need, regardless of their background or circumstances.”

“We are proud to learn that Dr. Hussain has been named an ASCO Advocacy Champion, and it is a well-deserved recognition of his passion and commitment to patient care and community oncology,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Dr. Hussain’s work with ASCO bridges the critical gap between community oncology practices and federal lawmakers and aligns with our company mission to ensure the viability of independent oncology practices. His involvement directly impacts health policy decisions and calls attention to the importance of having local cancer care options available. It is an honor to have Dr. Hussain in our network, and we are excited to witness what he accomplishes next through this platform.”

For the news, advocacy, and analysis on cancer policy, please visit www.asco.org/ascoaction.

For more information about AON, visit www.AONcology.com. For more information about Heartland Oncology & Hematology, visit www.heartlandoncology.com.  

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

About Heartland Oncology & Hematology
Heartland Oncology & Hematology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, we strive to provide the best treatment options, state-of-the-art equipment and best possible experience to patients and their families throughout the healthcare journey. Learn more at www.heartlandoncology.com.  

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

The Zangmeister Cancer Center Launches CPAN Chapter to Support Patient Advocacy Efforts

/in /by

Community oncology practice continues to focus on patient-first care and advocacy.

COLUMBUS, Ohio, April 30, 2024 –  The Zangmeister Cancer Center, a partner practice of American Oncology Network (AON) (Nasdaq: AONC), announced the launch of a local CPAN Chapter to support cancer patients and survivors and patient advocacy efforts.

“Having local cancer clinics that provide care and therapies is important to bridging the cancer care gap and ensuring patients can access these critical services close to where they live and work,” said Jeanna Knoble, MD, Board-certified medical oncologist at the Zangmeister Cancer Center. “We are excited to have launched a CPAN Chapter to facilitate important conversations about community oncology and healthcare policies affecting local, homegrown clinics. The Chapter will also serve as a platform for patients to have their voices heard on the importance of having local access to care and treatments and their experiences.”

CPAN (COA Patient Advocacy Network) is a “national organization formed to raise awareness of independent, community cancer care centers and how national and local healthcare policy issues affect patient care,” according to the Community Oncology Alliance’s (COA) CPAN website.

“CPAN Chapters are revolutionizing community oncology by highlighting the benefits independent practices deliver to patient care and outcomes,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “By supporting advocacy initiatives, like local CPAN Chapters, we can ensure that community oncology remains a key player and participant in vital healthcare policy discussions. The Zangmeister Cancer Center’s joining of CPAN will provide another avenue for advocacy of patient care in community settings, and it is with excitement that we congratulate the practice on getting involved with an esteemed initiative that will elevate cancer care for years to come.”

“We are honored to welcome the Zangmeister Cancer Center to CPAN,” said Rose Gerber, COA’s director of patient advocacy and education. “Accessible cancer care remains a critical issue in ongoing healthcare and government policy discussions. Unfavorable regulations and policies are forcing community oncology practices to close, jeopardizing patient access to critical care in their communities. Raising awareness of community oncology practices’ positive impact on patient care is crucial to ensure patients continue to receive high-quality care close to home.”

“I am honored to be serving as the liaison between our local and national CPAN efforts, working alongside Rose to strengthen the CPAN impact and reach,” said Dana Zager, MA, ATR-BC, MSW, LISW-S, OSW-C, ACHP-SW, Zangmeister Cancer Center’s Board-certified oncology social worker. “Bridging the gap between local and national initiatives creates a powerful network of support and advocacy for community oncology practices and their patients. Together, we can increase awareness, drive impact and ultimately, bring greater hope and better outcomes for everyone facing the cancer fight.”

The Zangmeister Cancer Center’s CPAN Chapter will be the third in Ohio and will join more than 30 community-based practices in over 15 states.

For more information about AON, visit www.AONcology.com. For more information about the Zangmeister Cancer Center, visit www.zangcenter.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

About Zangmeister Cancer Center
Designed for easy access and patient comfort, the center offers all of the services patients need as part of their cancer care, including diagnostic imaging and chemotherapy treatment, laboratory services, genetic consultation, a specialty pharmacy, social support services and access to cancer clinical trials. Our highly skilled and compassionate physicians use the latest advancements in the diagnosis, treatment and prevention of cancer and blood disorders. Learn more at zangcenter.com.  

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Lone Star Oncology and American Oncology Network Welcome New Board-Certified Physician to Care Team

/in /by

Dr. Sabbagh brings over 20 years of experience in treating various cancer types.

GEORGETOWN, Texas, April 29, 2024 –  Lone Star Oncology and American Oncology Network (AON) (Nasdaq: AONC), a rapidly growing national network of community-based oncology practices, is pleased to announce M. Hassan Sabbagh, MD, has joined the practice’s physician team and is accepting new patients.

Dr. Sabbagh is a Board-certified medical oncologist and hematologist who has been practicing for over 20 years in Texas. He received his Doctor of Medicine degree from Damascus University.

Upon graduating, he completed an internal medicine internship and residency at St. Barnabas Hospital in the Bronx, New York. He then finished a hematology-oncology fellowship at UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania.

“It is an honor to join Dr. Shimkus at Lone Star Oncology,” said Dr. Sabbagh. “My main commitment is to the well-being of my patients, and I am eager to contribute my skills and expertise to providing compassionate, comprehensive care at Lone Star Oncology. I look forward to building meaningful relationships with both patients and the care team and working together to promote health and healing within our community.”

“We are excited to welcome Dr. Sabbagh to Lone Star Oncology,” said Brian J. Shimkus, MD, Board-certified medical oncologist and hematologist at the practice. “His background and dedication to patient care will elevate our services. By expanding our physician team, we can now spend more time with our patients and increase the number of patients we see and treat. This is important because our patients can begin their treatments and therapies sooner. His joining will be of great benefit to our patients.”

Lone Star Oncology opened in June 2023 and joined AON simultaneously. The practice is led by Dr. Shimkus and his care team.

It is a community-based oncology and hematology practice specializing in treating patients diagnosed with cancers and blood disorders. Through its partnership with AON, it has expanded its patient services to include infusion therapy, centralized laboratory and pathology, oral cancer medication delivery, and financial counseling, among other benefits.

“AON’s growth into Texas began with our partnership with Lone Star Oncology and Dr. Shimkus,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “It is rewarding to see the practice’s growth to include a well-respected physician such as Dr. Sabbagh, whose background and experience will be of great value in serving their patients. We are thrilled to welcome Dr. Sabbagh to the network.”

For more information about AON, visit www.AONcology.com. For more information about Lone Star Oncology, visit www.lonestaronc.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

About Lone Star Oncology
Lone Star Oncology is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, we strive to provide the best possible experience to patients and their families throughout the healthcare journey. Learn more at www.lonestaronc.com. 

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada

/in /by

The Foundation, a non-profit of the American Oncology Network, provides grants for essential non-medical expenses to cancer patients in need.

FORT MYERS, Fla., April 25, 2024 – American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing community oncology networks, today launched its American Oncology Cares Foundation through its partner practices Hematology Oncology of Indiana in Indianapolis and Hope Cancer Care of Nevada in Las Vegas.

Non-medical expenses such as rent or mortgage, utilities, transportation costs and food qualify under the Foundation’s essential living expenses requirement. Grant recipients are eligible to receive up to $750 per calendar year.

Fifty-one percent of cancer patients have reported going into medical debt because of care and treatment costs and more than 70% responded that they are worried about affording their care, according to a survey by the American Cancer Society.

“The costs of cancer care and associated treatments can be devastating,” said Shelly Glenn, AON’s chief growth and relationship officer. “The Foundation was created to provide financial support for essential non-medical expenses to give peace of mind to adult cancer patients and their families. Unfortunately, It can be a common occurrence for patients to delay critical therapies, go without electricity or water, have their car repossessed or be evicted from their home, for example, to afford their care, and this tradeoff between care and essential resources should never be made. We are honored to launch the Foundation through our partner practices Hematology Oncology of Indiana and Hope Cancer Care of Nevada.”

Adult cancer patients currently undergoing treatment in Indiana and Nevada may now qualify for financial support through the Foundation. Other criteria for consideration include the following:

  • Be 18 years or older.
  • Have a household income that is at or below 200% of the U.S. Poverty Guidelines.

“Cancer treatments can reach incredible costs, depending on the diagnosis and personalized therapy plans,” said Raja S. Mehdi, MD, Board-certified medical oncologist and hematologist at Hope Cancer Care of Nevada. “Those in healthcare witness firsthand the financial burden families experience during treatments. The opportunity to have the American Oncology Cares Foundation an option for patients in Nevada is a critical step in ensuring people can focus on their health and recovery and less on their everyday expenses.”

“Financial burdens of cancer treatments should never be a barrier to ensuring the quality of life and that the basic expenses associated with living are met,” said Brian P. Mulherin, MD, Board-certified medical oncologist and hematologist at Hematology Oncology of Indiana. “We are honored to have the Foundation partner with us in their nationwide mission to provide financial support to cancer patients in need in Indiana.”

“The Foundation fills a crucial gap in the healthcare system,” said Todd Schonherz, AON’s chief executive officer. “Alleviating financial stress allows patients to focus their energy on recovery and empowers them to prioritize their health without the added stress of financial burdens. I am grateful we can bring the Foundation and its grants to Indiana and Nevada because we believe that financial well-being is just as important as physical well-being.”

The Foundation officially launched in October 2023 and leverages the non-profit America’s Charities to administer and manage the fund, review patient applications and distribute patient grants. While the fund currently operates solely in Arizona, Indiana, Nevada and Ohio, the intent is to expand the initiative with the hope that patients in all states in which AON operates will one day be able to benefit from the fund.

Patients who are interested in applying for a grant can complete the online application at www.charities.org/AONCares. Donations may also be made to the Foundation to support local cancer patients in need; to donate, visit www.AONcology.com/AONCares.

For more information about AON, visit www.AONcology.com. For more information about the American Oncology Cares Foundation, visit www.AONcology.com/american-oncology-cares.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Central Georgia Cancer Care Joins American Oncology Network to Elevate Local Cancer Care Delivery

/in /by

MACON, Ga., April 4, 2024 –  Central Georgia Cancer Care is excited to announce their partnership with the American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing networks of community-based oncology practices, to further strengthen their patient care and services by utilizing the network’s vast resources and expertise.

Central Georgia Cancer Care is a nationally recognized independent oncology practice known for providing personalized care close to home. They treat patients diagnosed with cancers and blood disorders at their clinics in Macon and Warner Robins. Their team includes four Board-certified medical oncologists; a supportive care physician Board-certified in hospice, palliative medicine, physical medicine and rehabilitation; and 11 advanced practice providers.

Additionally, the practice is dedicated to creating opportunities for clinical trial participation and establishing relationships with research hospitals to ensure patients have access to cutting-edge care and therapies in Central and South Georgia.

“We have been serving our community for over four decades, and it is our honor to be a part of our patients’ journeys,” said Bradley T. Sumrall, MD, Board-certified medical oncologist and managing partner of Central Georgia Cancer Care. “Our commitment to our patients’ well-being remains our top priority. To ensure seamless care, we’ve joined forces with the American Oncology Network, providing access to additional resources, support and experts. We are excited about this partnership and look forward to enhancing the services we offer our patients.”

Through the partnership with AON, the practice has access to added essential patient services and support, in addition to the high-quality care Central Georgia Cancer Care already provides. Resources available to the physicians and their patients include in-house pathology services, enhanced in-house specialty pharmacy for oral oncolytic medication and care coordination for patients, among other benefits.

“It is an exciting time when we welcome a new practice to our network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Central Georgia Cancer Care has been a cornerstone in the community for cancer patients for over 40 years, providing compassionate and personalized care and treatment plans to every patient who walks into the clinics. Our goal, as is with all our partners, is to provide access to essential services that alleviate the burden of running an independent medical practice so that the physicians can truly deliver patient-first care.”

“On behalf of AON’s leadership and the entire network, I would like to extend a welcome to Central Georgia Cancer Care, its physicians and care team,” said Todd Schonherz, AON’s chief executive officer. “Community practices that deliver critical care services, treatments and therapies help keep cancer care local and affordable for patients. It is our mission to support independent medical practices like Central Georgia Cancer Care to ensure it can continue serving its communities.”

For more information about AON, visit www.AONcology.com. For more information about Central Georgia Cancer Care, visit centralgacancercare.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

About Central Georgia Cancer Care
Since 1977, Central Georgia Cancer Care (CGCC) has provided high-quality, compassionate care to cancer and blood disorder patients in Central and South Georgia. Their physicians have laid the groundwork for cancer care advances through clinical trial participation and networking with research hospitals across the country to ensure each and every patient gets the most innovative, effective care. They are one of the few Georgia Oncology practices to be selected as a national Oncology Care Model practice and the only oncology center in the state with both Quality Oncology Practice Initiative (QOPI®) Certification and the American Society of Clinical Oncology’s (ASCO) Patient-Centered Cancer Care Certification for high-quality cancer care. The CGCC care team is fully committed to delivering world-class care without requiring its patients to leave the comfort of their community. Their board-certified physicians lead patient care, partnering with their advanced practitioners, nurses, patient navigators, patient account representatives and medical assistants to support the whole person’s well-being, not only the diagnosis. CGCC is shaping cancer care for the future. Learn more at centralgacancercare.com.  

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

American Oncology Network Expands to Hawaii, Welcomes New Practice to Network

/in /by

Hawaii Cancer Care partners with American Oncology Network to continue delivering quality cancer care to the community.

HONOLULU, April 3, 2024 –  American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing community oncology networks, is pleased to announce its expansion into Hawaii and welcomes Hawaii Cancer Care to the network.

“Our goal at AON is to partner with independent community oncology practices to further close the cancer care gap,” said Todd Schonherz, AON’s chief executive officer. “It is practices like Hawaii Cancer Care that are vital to the care delivery process ensuring patients have access to the care they need to treat their cancers and blood disorders. Independent medical practices that operate within communities, both large and small, offer significant benefits to patients, such as, limiting the distance traveled for care and often providing the same high-quality care and services at a more affordable price, which are critical components to the overall health journey. I’d like to welcome Hawaii Cancer Care and the care team to AON and am eager to witness the positive impacts they will continue to have in the community.”

Hawaii Cancer Care currently has clinics in Aiea and Honolulu to ensure cancer care is accessible to residents in the community. The facilities are equipped to deliver various cancer treatment modalities, including chemotherapy and immunotherapy as well as hormonal, targeted, biologic and certain cellular therapies.

The practice encompasses a team of highly trained Board-certified medical oncologists and hematologists: Jon S. Fukumoto, MD; Melvin P. Palalay, MD; David J. Tamura, MD; and Arnold K. Yee, MD, MPH. Additionally, the physician group is supported by a team of highly skilled and compassionate advanced practitioners to further provide patient care: Judy Ko, RN, MSN, APRN; Bryce Montalbo, DNP-FNP; and Ashley Mae Springer, RN, MSN, AGPCNP-BC.

“We are happy to be partnering with American Oncology Network,” said the physicians at Hawaii Cancer Care. “We are passionate about serving our local community with the highest level of care we can in an environment that is comfortable and supportive. Our approach to patient care revolves around creating treatment plans that are individualized and precision based. In our efforts to elevate our services, partnering with AON gives us the additional resources and support so that we can continue our patient-first care approach that we require from our care teams.”

“We are eager to welcome Hawaii Cancer Care to AON,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Hawaii is the newest state in our network, and we are honored to have the opportunity to bring our services, resources and support the patients of Hawaii Cancer Care. The practice already has a comprehensive menu of cancer care services that are valuable to patients at every stage in their diagnosis. While the practice has a solid foundation of services, we look forward to supporting the physicians and care team as they continue their mission to deliver high-quality patient care.”

For more information about AON, visit www.AONcology.com. For more information about Hawaii Cancer Care, visit hawaiicancercare.com.  

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

About Hawaii Cancer Care
Our team of doctors are highly recognized medical professionals with years of experience in cancer treatment. The doctors on staff have the expertise required to treat various types of cancers at various stages using the most recent proven advances in cancer care as well as education and support to our patients and their families. Our patient-focused, highly trained medical staff is here for you and ready to assist and support you with all your treatment needs. Learn more at hawaiicancercare.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

MiBA: A New Era in Data-Driven Oncology Insights for a Healthier Tomorrow

/in /by

The innovative healthcare technology startup utilizes data analytics to improve cancer care.

TAMPA, Florida., April 1, 2024 — Meaningful Insights Biotech Analytics (MiBA), an innovative healthcare technology company, is pleased to announce its official launch today and its commitment to transforming oncology, research and patient care. MiBA’s debut marks the successful synergistic partnership between industry leaders American Oncology Network (AON) (Nasdaq: AONC) and Ascend Technologies Group (ATG). The company is led by a team of industry visionaries: Todd Schonherz, Mark Moch, Jason Baroff, Scott Newman and Andrew T. Fisher, who collectively bring years of experience in technology, data science and oncology.

MiBA’s sophisticated platform empowers decision-makers throughout healthcare — physicians, health systems, biopharmaceutical companies and payers — with the data and tools necessary to accelerate research, optimize risk evaluation and reduce costs, enabling more accurate diagnoses and personalized treatment plans. These capabilities are integral components of MiBA’s comprehensive suite of services, reflecting its commitment to advancing healthcare insights on a broader scale.

Leveraging the combined strengths and expertise of AON and ATG, MiBA has gained the tools necessary to deliver its data-driven solutions. Specializing in navigating the complexities of oncology data, MiBA curates and applies advanced artificial intelligence (AI) technologies to extract meaningful insights accelerating advances in cancer care and patient outcomes. “Real world oncology data from the community is vast, complex, impactful but largely unexplored. MiBA is using cutting-edge AI approaches including natural language processing and large language models to unlock hidden insights from hundreds of thousands of oncology patients,” said Scott Newman, PhD, senior vice president of life sciences at MiBA.

“In the realm of cancer care, timely and accurate information is paramount for physicians to make informed health decisions on behalf of their patients, and our role in community oncology and AON is ensuring patients have access to the personalized care they require for their diagnoses,” said Todd Schonherz, chief executive officer at AON. “By leveraging the precision insights generated by MiBA, we are paving the way for more personalized and effective treatments, which ultimately benefits patients and lays the foundation that will propel the industry forward and its approach to patient care.”

“We believe in the power of data insights to guide today’s clinical decisions and illuminate the path towards tomorrow’s cures,” said Jason Baroff, managing partner at ATG. “We are honored to be powering the technology platform for precision insights. The platform is not just about innovation for its own sake; it’s a beacon of hope for patients worldwide.”

MiBA’s platform is comprehensive, with longitudinal data sourced from electronic medical record applications, clinical lab and pathology services, specialty pharmacy, practice management, diagnostic imaging, and next generation sequencing. Spanning over 25 community oncology practices across 20 states, and major growth plans to incorporate additional community oncology data sources, MiBA is poised to make significant contributions to oncology care. The company invites partners, healthcare professionals and the broader community to join in its journey towards harnessing the full potential of data-driven insights in the battle against cancer.

For practices looking to unlock and leverage their data assets to enhance clinical efficiency and productivity or for more information about MiBA and its services, visit www.mibanalytics.com.

###


About Meaningful Insights Biotech Analytics

MiBA is a healthcare AI technology company on a mission to close the feedback loop between physicians, patients, and industry partners. The technology and data insights that MiBA generates will support pharmaceutical companies, research organizations, payers, biotech, health systems and providers to advance the quality of patient care. Learn more at mibanalytics.com. 


About American Oncology Network

American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at www.AONcology.com. 


About Ascend Technologies Group

Ascend Technologies Group (ATG) is a services and consulting company with a focus on improvement of outcomes for the end user.  ATG layers its Cloud and Informatics practices on top of a robust portfolio of managed services, with a passion for bettering the patient experience, to deliver a diverse array of capabilities and areas of expertise in Healthcare IT.  Learn more at ascenditgroup.com.

American Oncology Network Announces Attendance and Participation at Leading Community Oncology Conference

/in /by

AON will attend the 2024 Community Oncology Conference as an exhibitor, and its leaders will serve as panelists in various educational sessions.

FORT MYERS, Fla., March 28, 2024 – American Oncology Network (AON) (Nasdaq: AONC) announced its attendance and panel participation at the annual Community Oncology Alliance (COA) conference from April 4 to April 5 in Orlando, Florida, to further its mission of closing the cancer care gap and ensuring the viability of community oncology.

“At AON, we are passionate about supporting the medical practices that reside in our hometowns because of the immense benefits they bring patients,” said Stephen “Fred” Divers, MD, AON’s chief medical officer, medical oncologist at Genesis Cancer and Blood Institute and co-chair of the COA conference. “We are embracing the conference’s theme of ‘Stronger Together’ and believe in the power of collaboration to improve clinical and patient outcomes, ensuring that there is a healthier future for cancer patients across the nation. I look forward to witnessing our leaders who will take the stage as panelists to share insights that we hope will resonate and guide our fellow colleagues in the industry.”

AON leaders invited to speak at the conference include the following individuals:

  • Jim Chen, MD, an AON consultant and incoming physician, is a panelist in the session “Is AI Ready for Prime Time for Cancer Care.”
  • Stephen “Fred” Divers, MD, is a panelist in the sessions “Welcome From the Co-Chairs,” “Defining Value in Oncology: Executing VBC Accurately & Ethically to Account for All Stakeholders,” “Reflections From the Co-Chairs” and “Meeting Observations From the Co-Chairs.” 
  • James Gilmore, PharmD, AON’s chief pharmacy and clinical services officer, is a panelist in the session “Managing Formularies: Successfully Navigating Multiple Formularies to Balance Clinical & Financial Outcomes.”
  • Mark Moch, AON’s chief information officer, is a panelist in the session “Preparing for Precision Medicine 2.0 in Community Oncology.”
  • Martin Palmeri, MD, MBA, medical oncologist at Messino Cancer Centers, is a panelist in the session “Hospitals: Friend or Foe? Examining Independent Practice-Hospital Relationships & Trends.”
  • Alti Rahman, MHA/MBA, CSSBB, AON’s chief strategy and innovation officer, is a panelist in the sessions “Welcome From the Co-Chairs,” “Guardians of Confidentiality: Navigating Cybersecurity & Data Privacy in Oncology,” “Is AI Ready for Prime Time for Cancer Care,” “Reflections From the Co-Chairs” and “Meeting Observations From the Co-Chairs.”
  • Jan Smithson, regional physician liaison manager for Genesis Cancer and Blood Institute, is a panelist in the session “Marketing Matters: Driving Provider Referrals in Competitive Marketplaces.”

AON is a fellow leader in the community oncology sector and dedicated to paving the way for independent practices to thrive independently with its support and resources, generating new revenue streams and growth in locations and patient services. Since its inception, AON has provided administrative support and access to critical offerings such as the in-house pharmacy and laboratory services to independent oncology medical practices.

Through the partnership with AON, physicians have the resources needed to focus on providing the highest standard of care to every patient while continuing to deliver comprehensive cancer care, therapies and expanded patient services in their clinics, reducing the reliance on larger health systems and other third-party companies.

“AON and COA share similar missions, which creates a strong foundation for impact in the community oncology industry, and we are excited to be involved in the COA conference this year,” said Rahman, AON’s chief strategy and innovation officer who also serves as co-chair of the COA conference. “In any sector of healthcare, the sharing of information, knowledge and best practices is important to achieving the necessary advancements in medicine. The conference brings together today’s healthcare and community oncology leaders for two days of education and networking. We understand the future of healthcare is a collective effort, and the conference provides a platform to foster unity and the exchange of information. At AON, we strive to be more than event attendees and seek to be catalysts for community oncology.”

AON is an exhibitor at the conference and can be found at booth 305.  

For more information about AON, visit www.AONcology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com